Bartonella quintana characteristics and clinical management

Emerging Infectious Diseases

Volumn 12, Issue 2, 2006, Pages 217-223

  Foucault, Cédric ^a   Brouqui, Philippe ^a   Raoult, Didier ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CHLORPHENOTANE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IVERMECTIN; MACROLIDE; MALATHION; PENICILLIN DERIVATIVE; PERMETHRIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL GENOME; BACTERIAL TRANSMISSION; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BARTONELLA QUINTANA; CLINICAL FEATURE; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DRUG TREATMENT FAILURE; GENUS; GRAM NEGATIVE BACTERIUM; HEMANGIOMATOSIS; HOMELESSNESS; HUMAN; HYGIENE; HYPEREOSINOPHILIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; NONHUMAN; PEDICULOSIS; PULSED FIELD GEL ELECTROPHORESIS; RICKETTSIOSIS; SERODIAGNOSIS; TAXONOMY;

EID: 33644546033     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1202.050874     Document Type: Article

References (40)

1. Raoult D, Roux V. The body louse as a vector of reemerging human diseases. Clin Infect Dis. 1999;29:888-911.
2. Karem KL, Paddock CD, Regnery RL. Bartonella henselae, B. quintana, and B. bacilliformis: historical pathogens of emerging significance. Microbes Infect. 2000;2:1193-205.
3. Maurin M, Raoult D. Bartonella (Rochalimaea) quintana infections. Clin Microbiol Rev. 1996;9:273-92.
4. Byam W, Carroll JH, Churchill JH, Dimond L, Sorapure VE, Wilson RM, et al. Trench fever. Oxford (UK): Oxford University Press; 1919.
5. McNee JW, Renshaw A, Brunt EH. "Trench fever": a relapsing fever occurring with the British forces in France. BMJ. 1916;12:225-34.
6. Kostrzewski J. The epidemiology of trench fever. Bull Acad Pol Sci (Med). 1949;7:233-63.
7. Brouqui P, Lascola B, Roux V, Raoult D. Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med. 1999;340:184-9.
8. Spach DH, Kanter AS, Dougherty MJ, Larson AM, Coyle MB, Brenner DJ, et al. Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med. 1995;332:424-8.
9. Brenner DJ, O'Connor SP, Winkler HH, Steigerwalt AG. Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from the order Rickettsiales. Int J Syst Bacteriol. 1993;43:777-86.
10. Birtles RJ, Harrison TG, Saunders NA, Molyneux DH. Proposals to unify the genera Grahamella and Bartonella, with descriptions of Bartonella talpae comb. nov., Bartonella peromysci comb. nov., and three new species, Bartonella grahamii sp. nov., Bartonella taylorii sp. nov., and Bartonella doshiae sp. nov. Int J Syst Bacteriol. 1995;45:1-8.
11. La Scola B, Raoult D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol 1999;37:1899-905.
12. Foucault C, Barrau K, Brouqui P, Raoult D. Bartonella quintana bacteremia among homeless people. Clin Infect Dis. 2002;35:684-9.
13. Rolain JM, Foucault C, Guieu R, La Scola B, Brouqui P, Raoult D. Bartonella quintana in human erythrocytes. Lancet. 2002;360:226-8.
14. Rolain JM, Foucault C, Brouqui P, Raoult D. Erythroblast cells as a target for Bartonella quintana in homeless people. Ann N Y Acad Sci. 2003;990:485-7.
15. Meghari S, Rolain JM, Grau GE, Platt E, Barrassi L, Mege JL, et al. Antiangiogenic effect of erythromycin: an in vitro model of Bartonella quintana infection. J Infect Dis. 2006;193:380-6.
16. Alsmark CM, Frank AC, Karlberg EO, Legault BA, Ardell DH, Canback B, et al. The louse-borne human pathogen Bartonella quintana is a genomic derivative of the zoonotic agent Bartonella henselae. Proc Natl Acad Sci U S A. 2004;101:9716-21.
17. Brouqui P, Stein A, Dupont HT, Gallian P, Badiaga S, Rolain JM, et al. Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore). 2005;84:61-8.
18. Rolain JM, Franc M, Davoust B, Raoult D. Molecular detection of Bartonella quintana, B. koehlerae, B. henselae, B. clarridgeiae, Rickettsia felis, and Wolbachia pipientis in cat fleas, France. Emerg Infect Dis. 2003;9:338-42.
19. La VD, Tran-Hung L, Aboudharam G, Raoult D, Drancourt M. Bartonella quintana in domestic cat. Emerg Infect Dis. 2005;11:1287-9.
20. Raoult D, Drancourt M, Carta A, Gastaut JA. Bartonella (Rochalimaea) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat. Lancet. 1994;343:977.
21. Zhang P, Chomel BB, Schau MK, Goo JS, Droz S, Kelminson KL, et al. A family of variably expressed outer-membrane proteins (Vomp) mediates adhesion and autoaggregation in Bartonella quintana. Proc Natl Acad Sci U S A. 2004;101:13630-5.
22. Jackson LA, Spach DH, Kippen DA, Sugg NK, Regnery RL, Sayers MH, et al. Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis. 1996;173:1023-6.
23. Ohl ME, Spach DH. Bartonella quintana and urban trench fever. Clin Infect Dis. 2000;31:131-5.
24. Fournier PE, Lelievre H, Eykyn SJ, Mainardi JL, Marrie TJ, Bruneel F, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore). 2001;80:245-51.
25. Raoult D, Fournier PE, Vandenesch F, Mainardi JL, Eykyn SJ, Nash J, et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med. 2003;163:226-30.
26. Koehler JE, Sanchez MA, Garrido CS, Whitfeld MJ, Chen FM, Berger TG, et al. Molecular epidemiology of Bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med. 1997;337:1876-83.
27. Koehler JE, Sanchez MA, Tye S, Garrido-Rowland CS, Chen FM, Maurer T, et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis. 2003;37:559-66.
28. Drancourt M, Moal V, Brunet P, Dussol B, Berland Y, Raoult D. Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient. J Clin Microbiol. 1996;34:1158-60.
29. Bernit E, Veit V, La Scola B, Tissot-Dupont H, Gachon J, Raoult D, et al. Bartonella quintana and Mycobacterium tuberculosis coinfection in an HIV-infected patient with lymphadenitis. J Infect. 2003;46:244-6.
30. Houpikian P, Raoult D. Western immunoblotting for Bartonella endocarditis. Clin Diagn Lab Immunol. 2003;10:95-102.
31. Fournier PE, Mainardi JL, Raoult D. Value of microimmunofluorescence for diagnosis and follow-up of Bartonella endocarditis. Clin Diagn Lab Immunol. 2002;9:795-801.
32. Vinson JW. In vitro cultivation of the rickettsial agent of trench fever. Bull World Health Organ. 1966;35:155-64.
33. Fenollar F, Raoult D. Molecular genetic methods for the diagnosis of fastidious microorganisms. APMIS. 2004;112:785-807.
34. Lepidi H, Fournier PE, Raoult D. Quantitative analysis of valvular lesions during Bartonella endocarditis. Am J Clin Pathol. 2000;114:880-9.
35. Gasquet S, Maurin M, Brouqui P, Lepidi H, Raoult D. Bacillary angiomatosis in immunocompromised patients. AIDS. 1998;12:1793-803.
36. Roux V, Raoult D. Inter- and intraspecies identification of Bartonella (Rochalimaea) species. J Clin Microbiol. 1995;33:1573-9.
37. Foucault C, La Scola B, Lindroos H, Andersson SG, Raoult D. Multispacer typing technique for sequence-based typing of Bartonella quintana. J Clin Microbiol. 2005;43:41-8.
38. Drancourt M, Roux V, Dang LV, Tran-Hung L, Castex D, Chenal-Francisque V, et al. Genotyping, Orientalis-like Yersinia pestis, and plague pandemics. Emerg Infect Dis. 2004;10:1585-92.
39. Foucault C, Ranque S, Badiaga S, Rovery C, Raoult D, Brouqui P. Oral ivermectin in the treatment of body lice. J Infect Dis. 2006; In press.
40. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48:1921-33.